Did You Know?

Editor’s Picks

Latest News

DELAYED AGAIN! Will Marijuana Rescheduling Survive Constitutional Challenges, Treaty Conflicts, and Federal Court Scrutiny?

Federally Compliant Pharmaceutical Developer Raises Constitutional, Statutory, Treaty, and Competitive Fairness Objections - Reserves Right to Seek Federal Court Review...

Medical Care Technologies Executes (OTC PINK:MDCE) Executes on Approximately $250,000 in Non-Dilutive Capital Generated Through Subsidiary Operations

Company prioritizes internal capital generation initiatives to support AI development, commercialization, and operational growth MESA, AZ / ACCESS Newswire /...

In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides

SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...

MMJ International Holdings Rejects “Anti-Marijuana” Label, Defends Science Based Standards for Cannabinoid Medicines

Clinical-Stage Pharmaceutical Developer Says Recent Coverage Misses the Real Story: Marijuana Chemistry, Safety, and Scientific Validation WASHINGTON, D.C. / ACCESS...

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health’s GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

The expanded agreement adds Filament Health, a wholly owned subsidiary of Red Light Holland, as a supplying affiliate and introduces...

error: Content is protected !!